Loading clinical trials...
Loading clinical trials...
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Conditions
Interventions
adalimumab
Methotrexate
Locations
92
United States
AZ Arthritis and Rheumotology Research, PLLC /ID# 21023
Phoenix, Arizona, United States
Catalina Pointe Clinical Research /ID# 40227
Tucson, Arizona, United States
Arkansas Children's Hospital /ID# 23505
Little Rock, Arkansas, United States
Children's Hospital Los Angeles /ID# 24386
Los Angeles, California, United States
Children's National Medical Center /ID# 23506
Washington D.C., District of Columbia, United States
Duplicate_Arthritis Associates South FL /ID# 17001
Delray Beach, Florida, United States
Start Date
July 11, 2008
Primary Completion Date
February 1, 2024
Completion Date
February 1, 2024
Last Updated
February 4, 2025
NCT06838143
NCT06870045
NCT05534347
NCT04902807
NCT04833465
NCT03245801
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions